Explore Boston's vibrant job market, where opportunities span industries like biotech, startups, and academia. Find your next career move with us. Browse our job board for the latest openings and take the next step in your Boston career journey.
The management jobs sector in the UK offers a diverse range of opportunities for professionals looking to lead and innovate across various industries. With roles spanning from project management to executive leadership, this dynamic field is essential for driving business success and organisational growth. As companies continue to evolve, the demand for skilled managers who can navigate complex challenges and implement effective strategies remains high. Explore our latest management job listings to find your next career move and become a key player in shaping the future of your industry.
962 Jobs Found for Mozart Therapeutics Inc in Boston
Director, Regulatory Affairs - Small Molecule Strategy Location: Boston, MA USA Monte Rosa Therapeutics is seeking a highly skilled and self-motivated regulatory professional to join our team as an Associate Director of Regulatory Affairs. This role will focus on oncology, immunology, and related therapeutic areas. The successful candidate will b...
As a Senior Computational Biologist at NextRNA Therapeutics, you will join an interdisciplinary team of highly creative and talented individuals whose mission is to bring a new class of small molecule medicines to patient in need. You will have a key role in identifying and validating novel long non-coding RNA targets. You will be a key team membe...
Director, Regulatory Affairs - Small Molecule Strategy Location: Boston, MA USA Monte Rosa Therapeutics is seeking a highly skilled and self-motivated regulatory professional to join our team as an Associate Director of Regulatory Affairs. This role will focus on oncology, immunology, and related therapeutic areas. The successful candidate will b...
Associate Director, Quality Control Reporting to the Senior Director, Analytical Development & Quality Control (QC), the Associate Director of Quality Control will be acting as QC lead, responsible for leading and managing the QC activities of PepGen’s pipeline. In addition, this position will be required to actively support the preparation of reg...
Company Summary: Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-30...
Company Summary: Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-30...
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person impacted by kidney disease and the renal community that serves them. Our tenacious, passionate employees challenge the status quo...
Verve is a clinical-stage genetic medicines company established with a mission to solve the global health epidemic of cardiovascular disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene-editing, Verve is pioneering a new approach to the care of cardiovascular disease, potentially transforming treatment from ...
Company Summary: Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-30...
Company Summary: Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-30...